GovBidAlerts
← All opportunities

Cryopreserved Platelets (CPP) for US FDA Licensure

Key dates

Posted
Apr 28, 2026
Response deadline
May 4, 2026, 7:00 PM UTC
Archive date
May 19, 2026
Archive type
auto15

Classification

Notice type
Sources Sought
Base type
Sources Sought
Set-aside
—
Set-aside code
—
PSC
—

NAICS

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE HEALTH AGENCY (DHA)
Office
ARMY MED RES ACQ ACTIVITY
Office code
097.97DH.HT9425
Organization type
OFFICE
Office address
FORT DETRICK, MD, 21702, USA

Place of performance

Street
—
Street 2
—
City
Frederick
State
Maryland
Zip
21702
Country
UNITED STATES

Contacts

Description

Defense Health Agency seeks to develop and manage medical materiel to protect and sustain the Warfighter on point for the Nation. We develop, directly through collaboration with commercial partners, medical products that enhance readiness and improve the quality of life of active-duty personnel in the operational environment. OPMED’s WPAC PMO has been developing a biologic product: Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP), a frozen, biologic-platelet product. DMSO CPP are formulated to provide a platelet-derived product with a longer shelf life (2 years and potentially longer) than liquid stored platelets (LSP), which are currently licensed for storage up to 5-7 days at room temperature (20’C to 24’C) under gentle agitation.

Attachments (1)

Other notices in this solicitation

Similar open contracts

Metadata

Notice ID
e2c26dc3937049faa715f6fa7fad2308
Full path
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).ARMY MED RES ACQ ACTIVITY
Office code
097.97DH.HT9425
Ingested
May 1, 2026
Updated
May 2, 2026